Abstract
Dupilumab (Dupixent®), a subcutaneously administered, fully human IgG4 monoclonal antibody directed against the IL (interleukin)-4 receptor α subunit, blocks the signalling of IL-4 and IL-13, two T helper cell type 2 cytokines implicated in the immunopathology of atopic dermatitis (AD). It is the first biologic therapy to have been approved for the treatment of adult patients with moderate-to-severe AD in the EU and USA. In phase III trials in adults with moderate-to-severe AD who were inadequately controlled with topical medications and/or systemic treatments, such as ciclosporin, or for whom these therapies were not advisable, 16 weeks' treatment with dupilumab as monotherapy or in combination with topical corticosteroids (TCS) improved multiple measures of disease severity, pruritus, sleep disturbance, anxiety and depression, and quality of life compared with placebo. Moreover, the benefits of combination therapy at week 16 were maintained during long-term treatment for up to 1 year. Dupilumab, alone or added to TCS, was generally well tolerated, with low rates of serious adverse events and treatment discontinuations due to adverse events. Common adverse reactions included conjunctivitis, injection-site reactions and oral he...Continue Reading
References
Jul 10, 2014·The New England Journal of Medicine·Lisa A BeckAllen R Radin
Dec 9, 2014·The Journal of Allergy and Clinical Immunology·Jennifer D HamiltonEmma Guttman-Yassky
Sep 18, 2015·Lancet·Stephan Weidinger, Natalija Novak
Nov 26, 2015·Immunotherapy·Jennifer D HamiltonEmma Guttman-Yassky
Jan 19, 2016·Journal of the American Academy of Dermatology·Eric L SimpsonVera Mastey
May 18, 2016·The Journal of Urology·David F Penson
Oct 4, 2016·The New England Journal of Medicine·Eric L SimpsonUNKNOWN SOLO 1 and SOLO 2 Investigators
Oct 26, 2016·CPT: Pharmacometrics & Systems Pharmacology·P KovalenkoR Soltys
Nov 16, 2016·International Archives of Allergy and Immunology·Adriana S MorenoMichael D Howell
Dec 28, 2016·Dermatology and Therapy·Matteo MegnaNicola Balato
Feb 7, 2017·Expert Review of Clinical Immunology·Magdalena Kraft, Margitta Worm
May 10, 2017·Lancet·Andrew BlauveltBrad Shumel
May 16, 2017·Dermatology and Therapy·Eric L Simpson
Jun 14, 2017·Journal of the American Academy of Dermatology·Laurent EckertJoel M Gelfand
Sep 10, 2017·The Journal of Allergy and Clinical Immunology·Amy S PallerThomas Bieber
Oct 4, 2017·The Journal of Allergy and Clinical Immunology. in Practice·Mark BoguniewiczMark Lebwohl
Oct 11, 2017·Journal of the American Academy of Dermatology·Patrick Fleming, Aaron M Drucker
Dec 2, 2017·The British Journal of Dermatology·M de Bruin-WellerB Shumel
Jan 11, 2018·Dermatology : International Journal for Clinical and Investigative Dermatology·Uffe NygaardMette Deleuran
Jun 6, 2018·Current Opinion in Allergy and Clinical Immunology·Yael Renert-Yuval, Emma Guttman-Yassky
Sep 6, 2018·Therapeutic Advances in Chronic Disease·Lieneke F M AriënsMarjolein S de Bruin-Weller
Citations
Jan 24, 2019·Expert Opinion on Biological Therapy·Randall LiEmma Guttman-Yassky
Mar 5, 2019·Allergy·D RusskampS Blank
Jul 30, 2019·European Journal of Immunology·Lorenzo CosmiFrancesco Annunziato
Feb 1, 2020·Expert Opinion on Biological Therapy·Jianni Wu, Emma Guttman-Yassky
Apr 3, 2020·Drugs·Sheridan M Hoy
Apr 9, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·C M OlesenT Agner
May 31, 2019·The British Journal of Dermatology·L E M de WijsD J Hijnen
May 28, 2019·Scientific Reports·Jung-Eun KimYong-Sung Kim
Feb 16, 2020·Science Immunology·Almog BittonAriel Munitz
Dec 5, 2020·Expert Review of Clinical Immunology·Carla Tubau, Lluís Puig
Jan 13, 2021·Immunotherapy·Carla Tubau, Lluís Puig
Jan 19, 2021·Pharmacological Reports : PR·Shirin KahremanyGuy Cohen
Feb 2, 2021·Dermatology and Therapy·Anne-Claire Fougerousse
Mar 24, 2021·The Journal of Dermatological Treatment·Natalie N BoytsovOrin M Goldblum
Mar 27, 2021·Clinical Case Reports·Matteo TrimarchiMario Bussi
Nov 20, 2020·Current Opinion in Immunology·Andrew P HearnDavid J Jackson
Nov 11, 2019·The Journal of Investigative Dermatology·Yi-Hsien ShihAnne Lynn S Chang
May 13, 2021·JAMA Dermatology·Jonathan I SilverbergKristian Reich
May 27, 2021·International Journal of Dermatology·Jordane BarbéAnne-Claire Busztejn
Jul 9, 2021·Frontiers in Cell and Developmental Biology·Chris M Li, Zhibin Chen
Jan 6, 2021·Dermatology : International Journal for Clinical and Investigative Dermatology·Mariateresa RossiPiergiacomo Calzavara-Pinton